18-20 April 2018
Bob McDowall, R.D. McDowall Ltd.
Karl-Heinz Menges, Regierungspräsidium Darmstadt
Yves Samson, Kereon AG
- Understand the current FDA and EU GMP regulations and guidance impacting data integrity from paper records to hybrid and electronic systems.
- Understand the FDA requirements for data integrity, MHRA Data Integrity guidance July 2016 and WHO guidance from September 2015.
- Learn what is required for a data governance system from senior management through to staff in laboratories, manufacturing and quality assurance.
- Understand the data life cycle and how it is linked with the business process and where problems can occur for both paper records, hybrid systems and electronic systems.
Data Integrity is a global problem and currently a major concern with FDA and European Regulatory Agencies. Multiple FDA warning letters and EU GMP non-compliance reports have highlighted major data integrity failures and falsification in companies globally. The regulatory concern has been responded by the FDA issuing Compliance Program Guide that covers Pre-Approval Inspections. This document became effective in May 2012. The CPG objective 3 covers the laboratory data integrity audit. Furthermore in August 2014, the FDA issued Level 2 guidance on their web site about the sharing of login credentials for computerized systems and the use of test injections for testing into compliance.
In Europe, the UK’s MHRA issued two versions of a Guidance for Industry on Data Integrity in January and March 2015. This document outlines a data integrity governance system and principles for defining quality and data integrity into processes and systems. In addition, the guidance defines 19 terms and provides expectations and examples for many of them and therein is where the document’s value lies. A new draft version of the Guidance was published in July 2016. The WHO guidance is complimentary to the MHRA guidance in that it provides guidance for data governance and also expectations for records in both paper and electronic form.
As the regulators are tightening their inspection approaches it is important that managers, supervisors and users in regulated GMP laboratories understand the issues around data integrity and begin programs to ensure that their processes and systems ensure data integrity.
This course is designed for managers and staff from health care industries as well for auditors who are responsible for the organisation and execution of audit trail (reviews) in their companies.
ProgrammeWhy is Data Integrity Important? – Setting the Scene
Data Integrity – EU GMP Requirements
- Summary of falsification observed by FDA and EU inspectors 2005 – to date
- FDAISA act 2012 and October 2014 Guidance for Industry and the impact on inspections
- Inspection of computerised systems is changing: from paper to on-line
- MHRA expectation for data governance; data integrity guidance documents 2016
- FDA Level 2 guidance on data integrity: 2010 and 2014 postings
- Impact of WHO guidance for data integrity
Principles of Data Integrity
- EU GMP Chapter 4 – documentation
- EU GMP Annex 11 computerised systems
- Data integrity definitions
- Difference between paper and electronic systems
Facilitated Discussion / Workshop on Key Data Integrity Topics
- The ALCOA+ criteria for data integrity
- Data life cycle in the process workflow – managing controls
- Paper versus hybrid versus electronic systems
- Validation of computerised systems for data integrity controls
- Scope: production information versus laboratory data: why are laboratory data higher risk?
WHO, MHRA and GAMP Data Integrity Guidances - Key Points
- Recording results on paper
- Configuration of software applications
- Unique user identities for all users
- Unauthorised access
- Appropriate access privileges for each user role
- Is my chromatographic system ready? Role of “test” injections
- Audit trails – options for older systems
- Manual chromatographic integration
- Standalone versus network systems
- Protecting electronic records of standalone systems
FDA Draft Guidance for Industry ‘Data Integrity and Compliance with cGMP’
- Data Governance System within the Pharmaceutical Quality System
- Data Life Cycle
- Spectrum of Systems: Paper to Electronic Systems with data integrity audit
- The GAMP Records and Data Integrity Guide
Role of Management in Data Integrity
- Questions and Answers regarding Data Integrity
Development and Scope of a Data Governance System
- Role of Senior, Production and Department Management in ensuring data integrity within an organisation and its suppliers
- Data governance within a Quality System
- Failures to address poor data integrity practices and no training
Implementing Data Integrity Training
- Within a PQS, what is the scope of a data governance system?
- Who are involved?
- What are their roles?
US 21 CFR 211 and EU GMP Chapter 4: Complete data vs raw data vs primary record
- Scope of data integrity training
- What cover in the training?
- Checking training effectiveness
- Integrating data integrity training with GMP training
Case study: Data Integrity questions as part of an inspection
- Why complete data and raw data are important for understanding data integrity
- EU GMP Chapter 4 requirements for raw data
- 21 CFR 211 requirements for laboratory records: complete data
- FDA Level 2 guidance: paper versus e-records
- Complete data / raw data / primary record example
- Lab System
- QA System
- Manufacturing Syste
Data Integrity in paper documentation
User Account Management and Application Configuration
- GMP requirements for good documentation practice
- Application to paper documents
- Common problems from FDA 483 observations and warning letters and how to avoid them
IT Support for Data Integrity
- Separation of roles and responsibilities between IT and the business
- Documentation of the configuration of an application e.g. audit trail, user types and access privileges
- User account management: the dos and don’ts
- User identities must be unique
- Regular review of each system users and privileges
Software Suppliers Responsibility for Data Integrity Compliance
- IT facilities, environmental controls and physical security
- Qualified IT infrastructure and validated IT systems
- Backup and recovery / Change control
- IT support including database administration
- Impact of IT infrastructure on data integrity
Case study: Can Spreadsheets meet Data Integrity requirements?
- Regulatory requirements for software systems: procedural and technical
- Role of software suppliers
- Regulations push v market needs pull
- Implementing technical requirements for software: architecture, database and application
- Marketing literature versus marketing bullshit
Supply Chain Data Integrity – Organisational Interfaces
- Problems with spreadsheets
- Good Practice for using spreadsheets in a regulated environment
- Building data integrity features into a spreadsheet
Key Learning Points and Final Discussion
- Approaches to ensuring data integrity of your suppliers
- Role of technical agreements and audits
Workshop: Analysis of an FDA Warning Letter
- Summary of Data Integrity Requirements and Key Learning Points
- Final Discussions and close of the course
Working in teams, attendees will analyse one of several FDA warning letters to identify key areas of regulatory concern
Group discussion of regulatory concerns identified
Workshop: How to write testable requirements for Data Integrity
Workshop: Assessing a System for Data Integrity
Using a checklist based on the data integrity criteria, attendees will assess a system for data integrity